Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
Search Tags: health
Patrick Skerrett of Harvard Health Letter offers tips for tuning out noisy distractions in your office.
Using a cutting edge process to form new joints inside the body, a team of researchers funded by the National Institutes of Health has successfully regenerated rabbit joints. The experiment demonstrates that it's possible to grow dissimilar tissues, like cartilage and bone, taken entirely from the host's own cells. The regenerative procedure is performed by stimulating previously irreparable organs or tissues to heal themselves. Three-dimensional structures made of biocompatible and biodegradable materials in the shape of the tissue, are infused with a protein to promote the joint's growth. The approach sidesteps several problems that are typically encountered in trying to transplant cells that are grown externally, such as tissue rejection. Future work could replace arthritic joints in animals and ultimately in arthritis patients who need total joint replacement.
Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs like aspirin have lower incidences of certain types of cancer. Now, in a study appearing in Cancer Cell magazine, investigators at Sanford-Burnham Medical Research Institute and their colleagues have figured out how one such drug, called Sulindac, inhibits the growth of tumors. The study reveals that the drug shuts down cancer cell growth, and initiates the death of cells by binding to a nuclear receptor, that can then turn genes on or off. Sulindac is currently prescribed for the treatment of pain and fever, and to help relieve symptoms of arthritis. The current study demonstrates a new application as a potential anti-cancer treatment that targets certain kinds of tumors.
A study funded by the National Institutes of Health - using an electro-encephalogram, a machine that records the brain's electrical activity - shows newborn infants are capable of a simple form of learning while they're asleep. The finding may one day lead to a test that can identify infants at risk for developmental disorders. The NIH National Institute of Child Health and Human Development sponsors research on development, before and after birth. The machine measured the babies brain's electrical activity while a video camera recorded each baby's facial expressions, as researchers played a tone, as a machine blew a puff of air at each sleeping infant's eyelids. The electroencephalogram detected changes in brain wave activity that occurred simultaneously with the tone, showing the infants had learned to associate the tone with the puff of air.
The new mandated International Classification of Diseases, 10th edition (ICD-10) must be implemented by October 1, 2013. ICD-10—a complete replacement of the ICD-9 code sets used to report healthcare diagnoses and procedures—will affect all segments of the healthcare industry, including providers, clearinghouses and health plans, as well as government agencies.
ICD-10, however, is more than an IT effort. It is a regulation that has a large impact on policies, business operations, clinical processes, and healthcare outcomes research. Preparing for ICD-10 will require an organization-wide approach and an understanding of all the areas impacted by its adoption.
Noblis—a nonprofit science, technology and strategy organization with a proven record of success working on ICD-10—is pleased to facilitate a panel discussion to exchange information and ideas among key public and private sector stakeholders. Together, the panel experts will discuss the risks and opportunities of the ICD-10 transition, what their organizations are doing now to get started, and where ICD-10 fits compared to other large initiatives.
Tags: technology , healthcare , Robert J. Clerman , Noblis , Noblis Insights Panel , Todd Couts , Jacqueline Gibbons , Northern Virginia Community College , Marcia L. Insley , Sonja Racke , National Government Services , education , ICD-10
Research out of Wayne State University finds people who smile really do live longer.
National Institute of Allergies and Infectious Diseases
September 21st and September 23rd
U.S. Rep. Barbara Lee (D-Calif.)
Author, "Renegade for Peace & Justice: Congresswoman Barbara Lee Speaks for Me"
Co-Director, Campaign for America's Future
Former chief of staff, House Aging Committee and Health Subcommittee
AFGE Public Policy Director
President Barack Obama has appointed Dr. Mary Wakefield as the administrator of the Health Resources and Services Administration (HRSA).